Drug Development

Breaking News | cGMP Manufacture | Drug Development | Industry News

Everest Medicines, Sinovent, SinoMab Enter Global BTK Inhibitor Mfg. Pact

To develop, produce and commercialize XNW1011, a covalent reversible BTK inhibitor, globally for the treatment of renal diseases.

09.17.21

Breaking News | Drug Development | Industry News

Diadem Biotherapeutics Awarded the First Amgen Golden Ticket

Will receive one year of lab space at BioLabs LA at The Lundquist Institute and additional facility benefits and connections to Amgen's scientific leaders.

09.15.21

Breaking News | Drug Development | Drug Discovery | Industry News | Information Technology

Novo Nordisk Launches Foundation Center for Genomic Mechanisms of Disease

Initiative, together with the Broad Institute of MIT and Harvard, aims to accelerate efforts to mine genetic data for insights into disease mechanisms.

09.15.21

Drug Development | Laboratory Testing

Eliminating Endotoxins – Reagent Quality Testing for Cell and Gene Therapies

The importance of reagent quality control, especially endotoxin testing, during CGT development and the selection of reagents and suppliers to ensure safety.

Garrett Perry, Technical Services Specialists at Teknova 09.14.21

Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Drug Development

AbbVie, REGENXBIO Enter Eye Care Collaboration

Strategic partnership combines eye care and gene therapy expertise.

09.13.21

Clinical Trials | Drug Development

Supporting Product Regulatory Decision Making with RWE

Leveraging powerful evidence that can be instrumental in filling knowledge gaps for regulatory submissions.

Nancy Dreyer, Chief Scientific Officer at IQVIA Real World Solutions 09.10.21

Breaking News | Collaborations & Alliances | Drug Development

GeneQuine Contracts Exothera to Support the Development of Its Osteoarthritis Gene Therapy

GQ-303, the gene therapy candidate, turns joint cells into factories for production of the therapeutic protein proteoglycan 4.

09.10.21

APIs | Drug Development

API Development Trends

Why is it important to consider solid form in API development?

John Mykytiuk, Jamie Marshall and Andrew Blythe-Dickens, Sterling Pharma Solutions 09.09.21

Biologics, Proteins, Vaccines | Drug Development

How to Speed Up Vaccine Development and Production With Genetic Vaccine Technology

We explore the challenges and pitfalls in developing new genetic vaccines, and in manufacturing them following approval.

Drug Development

Partnering with a CDMO for Orphan Drug Development

Challenges and considerations for advancing rare disease drugs to market.

Susan Billings, Vice President & Global Head of Business Development, Curia (formerly known as AMRI) 09.09.21

APIs | Drug Development

Access the Advantages of Spray Drying with an Experienced API CDMO

Spray drying is experiencing huge demand as the number of poorly soluble small molecule drugs grows.

cGMP Manufacture | Drug Development | QA/QC

Three Tips for Navigating Post-Approval Pharmacovigilance

Seamlessly transition from regulatory reporting to post-approval safety surveillance in today’s market.

Emmanuel Belabe, Associate Vice President, Safety Product Management, ArisGlobal, Nina Patel Lahanis, Associate Vice President, Safety Science, EVERSANA 09.08.21

Breaking News | Collaborations & Alliances | Drug Development | Drug Discovery

Adaptimmune, Genentech Enter Strategic R&D Collaboration

To research, develop, and commercialize cancer-targeted Allogeneic T-cell therapies.

09.07.21

Breaking News | Collaborations & Alliances | Drug Development | Drug Discovery

Secarna, Evotec Expand Strategic Antisense Discovery Pact

To discover, research and develop programs leveraging Secarna’s antisense oligonucleotide expertise with Evotec’s discovery and development capabilities.

09.02.21

Virpax Inks MMS019 Manufacturing and Supply Agreement

CDMO Seqens to provide clinical and commercial supply of MMS019.

08.30.21

Breaking News | Drug Development | Industry News

Innovent Biologics, Bolt Biotherapeutics Enter Immuno-oncology Alliance

Will leverage Innovent's therapeutic antibody portfolio and discovery capability against undisclosed oncology targets in combination with Bolt's ISAC technology

08.27.21

Breaking News | Collaborations & Alliances | Drug Development | Industry News

SignalRx, Crystec and ADYA Partner to Develop Treatment for SARS-CoV-2 Related Illnesses

Aim to develop an inhaled dry powder formulation of SF2523.

08.26.21

Breaking News | cGMP Manufacture | Drug Development | Industry News

ExoCoBio to Build World’s First Clinical Grade Exosome GMP Mfg. Facility

Will invest approximately $20 million to install two types of advanced exosome production lines in Osong South Korea.

08.25.21

Drug Development | Drug Discovery

Antimicrobial Resistance ‘Arms Race’ Realizes Advancements as Post-Antibiotic Era Ensues

Emerging innovations and non-antibiotic approaches to address urgent need to control infectious diseases, including multiple-drug resistant ‘super-bugs’

Merilee Kern 08.18.21